Clinical Trial Update: The Study of the BX Velocity Stent in the Treatment of De Novo Artery Lesions. [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the BX Velocity Stent for de novo coronary artery lesions in coronary artery disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• BX Velocity Stent

Snippet

Sponsor: Cordis US Corp. | Conditions: Coronary Artery Disease | Phase 3 | Status: COMPLETED